The clinical-stage biotech might have a successful drug on its hands, if a relatively early-stage clinical trial is any indication. Its REC-4881 did very well in the testing. 10 stocks we like better ...

A major outage at internet infrastructure firm Cloudflare knocked parts of the internet offline, disrupting access to X, NJ Transit, ChatGPT and other major platforms ...

Recursion Pharmaceuticals owns the largest supercomputer in the pharmaceutical industry. However, Eli Lilly is starting to build one that could be even more powerful once it's completed. With its ...

In Hans Christian Andersen's folktale, The Emperor's New Clothes, when a child cries out that the emperor is naked, he isn't revealing a secret. Everyone already knows it. What changes in that instant ...

At Build 2025, SQL Server 2025 officially entered public preview. As one of the world’s most popular databases, this release continues a decades-long history of innovation with features made for ...

Microsoft has resolved a known issue that caused some Windows Server 2025 domain controllers to become unreachable after a restart and triggered app or service failures. As Redmond explained when it ...

June 10 (Reuters) - Recursion Pharmaceuticals (RXRX.O), opens new tab said on Tuesday it would lay off about 20% of its workforce as the biotech company tries to cope with an industry-wide funding ...

Recursion said today it is eliminating approximately 20% of its workforce—about 160 jobs—in a restructuring the AI-based drug developer said reflects both its recently-pruned pipeline and the ...